The expression of IGF2BP3 is related to disease recurrence and cancer-specific mortality in urothelial carcinoma, which could improve risk stratification of urothelial carcinoma patients undergoing radical nephroureterectomy [44]. The gene discussed is IGF2BP3; the disease is urothelial carcinoma.